TS
BMY icon

Tamar Securities’s Bristol-Myers Squibb BMY Stock Holding History

Tamar Securities’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$430K Sell
7,082
-907
-11% -$52.9K 0.05% 59
2025
Q4 		$431K Sell
7,989
-5,427
-40% -$261K 0.05% 58
2025
Q3 		$605K Sell
13,416
-329,066
-96% -$15.4M 0.07% 53
2025
Q2 		$15.9M Buy
342,482
+17,027
+5% +$836K 1.92% 24
2025
Q1 		$19.8M Sell
325,455
-92,655
-22% -$5.4M 2.69% 15
2024
Q4 		$23.6M Buy
418,110
+3,950
+1% +$221K 3.26% 10
2024
Q3 		$21.4M Buy
414,160
+33,073
+9% +$1.55M 3.01% 12
2024
Q2 		$15.8M Buy
381,087
+93,685
+33% +$4.19M 2.57% 14
2024
Q1 		$15.6M Buy
287,402
+52,993
+23% +$2.7M 2.63% 12
2023
Q4 		$12M Buy
234,409
+27,758
+13% +$1.46M 2.36% 21
2023
Q3 		$12M Buy
206,651
+32,368
+19% +$1.98M 2.89% 9
2023
Q2 		$11.1M Buy
174,283
+24,068
+16% +$1.61M 2.74% 12
2023
Q1 		$10.4M Buy
150,215
+13,665
+10% +$964K 2.99% 12
2022
Q4 		$9.82M Buy
136,550
+250
+0.2% +$18.9K 3.12% 12
2022
Q3 		$9.69M Buy
136,300
+27,259
+25% +$1.98M 3.1% 9
2022
Q2 		$8.4M Sell
109,041
-25,926
-19% -$1.97M 2.76% 15
2022
Q1 		$9.86M Buy
134,967
+3,430
+3% +$230K 2.75% 14
2021
Q4 		$8.2M Sell
131,537
-3,676
-3% -$216K 2.42% 15
2021
Q3 		$8M Buy
135,213
+9,698
+8% +$639K 2.89% 12
2021
Q2 		$8.39M Buy
125,515
+12,985
+12% +$847K 3.23% 11
2021
Q1 		$7.1M Buy
112,530
+19,357
+21% +$1.2M 2.75% 12
2020
Q4 		$5.78M Buy
93,173
+8,106
+10% +$498K 3.29% 10
2020
Q3 		$5.13M Buy
85,067
+16,303
+24% +$981K 3.19% 10
2020
Q2 		$4.04M Buy
+68,764
New +$4.11M 3.22% 11

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tamar Securities's BMY Position: Q1 2026 in Review

Tamar Securities reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q1 2026, selling an estimated $52.9K and leaving 7,082 shares worth $430K. The position accounts for 0.05% of the portfolio, ranked #59.

Tamar Securities first reported a position in BMY in Q2 2020 and has held it in 24 quarters since. The position peaked at $23.6M in Q4 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Tamar Securities held 7,082 shares of Bristol-Myers Squibb worth $430K as of Q1 2026.
  • Tamar Securities sold 907 Bristol-Myers Squibb shares in Q1 2026, an estimated $52.9K.
  • Bristol-Myers Squibb made up 0.05% of Tamar Securities's portfolio in Q1 2026, its #59 holding.
  • Tamar Securities first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 24 quarters since.
  • Tamar Securities's Bristol-Myers Squibb position peaked at $23.6M in Q4 2024.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tamar Securities's 13F filing for Q1 2026, filed 14 May 2026.